Assessing risk and benefit communication in direct-to-consumer medication web site advertising

Vigilante, W. J.; Wogalter, M. S.

Citation

258. Vigilante, W. J., & Wogalter, M. S. (2005). Assessing risk and benefit communication in direct-to-consumer medication web site advertising. Drug Information Journal, 39, 3-12.

Publication Details

Source: Drug Information Journal
Volume: 39
Pages: 3-12

Publication Type

Journal Articles

Research Topics

Health & Medical Human Factors, Human-Computer Interaction & Usability

View / Download Publication PDF

Related Research

Other items sharing Mike's expert research categories.

A Communication–Human Information Processing (C–HIP) approach to warning effectiveness in the workplace — View PDF
A comparison of older v. newer over-the-counter (OTC) nonprescription drug labels on search time accuracy — View PDF
A forensic HF/E analysis of a trip and fall injury event involving a wheel stop in a parking lot — View PDF
A perceptual analysis of standard safety, fluorescent, and neon colors — View PDF
A personalized speech warning facilitates compliance in an immersive virtual environment — View PDF

Copy / Export Citation

258. Vigilante, W. J., & Wogalter, M. S. (2005). Assessing risk and benefit communication in direct-to-consumer medication web site advertising. Drug Information Journal, 39, 3-12.

Download RIS | Download BibTeX

Exported citations use the available record metadata. Check formatting before academic use.